GCA
AGN

Greenwood Capital Associates’s Allergan plc AGN Stock Holding History

Greenwood Capital Associates’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-20,560
Closed -$3.92M – 220
2018
Q3 		$3.92M Buy
20,560
+5,010
+32% +$920K 0.85% 50
2018
Q2 		$2.59M Buy
+15,550
New +$2.5M 0.6% 65
2016
Q1 		– Sell
-6,532
Closed -$2.04M – 180
2015
Q4 		$2.04M Buy
+6,532
New +$1.94M 0.66% 67

Other funds holding AGN

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Edgewood Management
Edgewood Management Greenwich, Connecticut $15.5B AUM 9.67% 1-Year Est. Return
LP
Longview Partners St Peter Port, Guernsey $7.06B AUM 3.43% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return

Greenwood Capital Associates's AGN Position: Q4 2018 in Review

Greenwood Capital Associates sold out of Allergan plc (AGN) in Q4 2018, closing a stake of 20,560 shares — an estimated $3.92M sold.

Greenwood Capital Associates first reported a position in AGN in Q4 2015 and held it in 3 quarters. The position peaked at $3.92M in Q3 2018. 1,007 funds tracked by Wall St. Rank hold AGN as of Q4 2018.

  • Greenwood Capital Associates reported no remaining Allergan plc position as of Q4 2018 after selling out during the quarter.
  • Greenwood Capital Associates sold 20,560 Allergan plc shares in Q4 2018, an estimated $3.92M.
  • Greenwood Capital Associates first reported a position in Allergan plc in Q4 2015 and held it in 3 quarters.
  • Greenwood Capital Associates's Allergan plc position peaked at $3.92M in Q3 2018.
  • 1,007 funds tracked by Wall St. Rank held Allergan plc as of Q4 2018.

Based on Greenwood Capital Associates's 13F filing for Q4 2018, filed 11 Feb 2019.